According to the latest report by IMARC Group, titled “Diabetic Socks Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global diabetic socks market size reached US$ 208.8 Million in 2022. Diabetic socks are designed to provide maximum comfort, protection, and support for individuals with diabetes. These socks are manufactured from moisture-wicking materials, such as acrylic or merino wool, which help keep the feet dry by drawing moisture away from the skin. Additionally, diabetic socks are often seamless or have flat seams to minimize friction and reduce the risk of blisters, sores, or ulcers. They provide extra padding in areas prone to pressure points, including the heel and the ball of the foot, to prevent injuries and distribute pressure more evenly. Diabetic socks have a non-binding or loose-fitting design that promotes healthy blood flow and does not constrict circulation. It offers several benefits, such as maintaining proper foot hygiene, reducing the risk of foot ulcers, preventing moisture-related complications, and enhancing overall foot comfort.
Global Diabetic Socks Market Trends:
The global market is majorly driven by the rising prevalence of diabetes among individuals. Moreover, the growing awareness among the masses about the importance of foot health and the potential risks associated with foot complications is contributing to the growth of the market. Apart from this, the increasing healthcare expenditure globally, particularly in diabetes management and prevention, is creating a positive market outlook. Furthermore, several leading players are developing socks with integrated sensors, enabling users to monitor foot temperature and transmit the data to smartphones through a dedicated application, which is providing a boost to the market. Along with this, governments are raising awareness about diabetes management and foot care by organizing campaigns and education programs and providing funding for research and development in diabetes-related, thus impacting the market favorably. Other factors, such as increasing focus on preventive healthcare, focus on preventing lower extremity amputations, adoption of multidisciplinary care approaches, and ongoing research and development activities, are also influencing the market. Looking forward, the market value is projected to reach US$ 284.7 Million by 2028, expanding at a CAGR of 5.5% during 2023-2028.
- Based on the product, the market has been segmented into ankle length, calf length, and knee-length.
- On the basis of the distribution channel, the market has been divided into supermarkets and hypermarkets, pharmacy and drug stores, online stores, and others.
- Based on the material, the market has been bifurcated into polyester, cotton, nylon, spandex, and others.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being 3M Company, BSN medical GmbH (Essity AB), Creswell Sock Mills, Cupron Inc., DJO LLC (Colfax Corporation), Orthofeet Inc., PediFix Inc., Sigvaris Group, Simcan Enterprises Inc., Syounaa and Thorlo Inc.
|Base Year of the Analysis
||Product, Distribution Channel, Material, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3M Company, BSN medical GmbH (Essity AB), Creswell Sock Mills, Cupron Inc., DJO LLC (Colfax Corporation), Orthofeet Inc., PediFix Inc., Sigvaris Group, Simcan Enterprises Inc., Syounaa and Thorlo Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800